COMMENTARY: Dear Gilead: Please Add A Placebo Arm To Remdesivir Trial

A randomized trial of the antiviral remdesivir for the treatment of COVID-19 is underway but its open label design and lack of a placebo control raises concerns for John Mandrola, MD